GreenBear
06/06/13 23:49
Ha respondido al tema Farmas USA
Ir a respuesta
Algo más de información sobre la compra del CEO, que al parecer, tiene buen timing. La acción ya está en 4.50 en after hours. Mola :)
"Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) CEO Safi R. Bahcall disclosed the purchase of 10,000 shares on 6/6 at $4.40. The insider buy follows the major sell-off in the stock post ASCO. In addition to buying by the CEO, Director and larger shareholder Bruce Kovner recently disclosed the purchase of 2 million shares.
Bahcall has had a pretty good track record on insider buying timing.
Shares of Synta are down 70% since May 31 following survival results From GALAXY-1 Phase 2b/3 Trial of Ganetespib in second-line non-small cell lung cancer at ASCO. The company called the results "positive," although others are questioning their significance."
http://www.streetinsider.com/Insider+Trades/Synta+Pharmaceuticals+%28SNTA%29+CEO+Steps+Up+with+Buy+Post+70%25+Collapse/8398397.html
.
Mañana toca subida buena.